The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
SJS Enterprises Ltd
NSE:SJS
|
IN |
|
I
|
International Consolidated Airlines Group SA
MAD:IAG
|
UK |
|
F
|
Frontdoor Inc
F:3I5
|
US |
|
N
|
NH Special Purpose Acquisition 30 Co
KOSDAQ:466910
|
KR |
|
M
|
Mfe-Mediaforeurope NV
MIL:MFEA
|
IT |
|
S
|
STAAR Surgical Co
SWB:SR3
|
US |
|
E
|
Eugene Special Purpose Acquisition 10 Co
KOSDAQ:468760
|
KR |
|
S
|
SMAIO SA
F:G3O
|
FR |
|
Buccaneer Energy PLC
LSE:BUCE
|
UK |
|
Grupo Ezentis SA
MAD:EZE
|
ES |
|
Food & Life Companies Ltd
F:2G0
|
JP |
|
E
|
ESE Entertainment Inc
OTC:ENTEF
|
CA |
|
A
|
Air China Ltd
XMUN:AD2
|
CN |
|
Hansard Global PLC
LSE:HSD
|
IM |
|
F
|
Fuel Tech Inc
XMUN:FUE1
|
US |
|
Cohort PLC
LSE:CHRT
|
UK |
|
K
|
Kerry Properties Ltd
OTC:KRYPY
|
HK |
|
Erie Indemnity Co
F:EI2
|
US |
|
C
|
CVD Equipment Corp
F:0V3
|
US |
|
China High Speed Transmission Equipment Group Co Ltd
OTC:CHSTY
|
KY |
|
S
|
Sellas Life Sciences Group Inc
F:RXK3
|
US |
|
Blue Lagoon Resources Inc
F:7BL
|
CA |
SJS Enterprises Ltd (SJS)’s 12-month stock price forecast through October 2027 has a consensus target of ₹2 836.11, implying 50% upside. The forecast is based on price targets from 5 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
SJS is 2 836.11 INR with a low forecast of 2 479.55 INR and a high forecast of 3 097.5 INR.
Over the last 6 years, the compound annual growth rate for Revenue has been 28%. The projected CAGR for the next 3 years is 21%.
Over the last 6 years, the compound annual growth rate for Gross Profit has been 25%. The projected CAGR for the next 2 years is 25%.
Over the last 6 years, the compound annual growth rate for Operating Income has been 28%. The projected CAGR for the next 3 years is 22%.
Over the last 6 years, the compound annual growth rate for Pre-Tax Income has been 27%. The projected CAGR for the next 3 years is 25%.
Over the last 6 years, the compound annual growth rate for Net Income has been 27%. The projected CAGR for the next 3 years is 24%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
AI-generated answers can contain mistakes, outdated facts, or incomplete information. Always verify important details before making decisions.
The AI Assistant is designed for research and education. It does not provide personalized investment, legal, or tax advice.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more